Evidence map›Paper›PMID 25561462›Full record

ArticleJournal of lipid research2015

HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function.

Stela Z Berisha, Greg Brubaker, Takhar Kasumov, Kimberly T Hung, Patricia M DiBello, Ying Huang, Ling Li, Belinda Willard, Katherine A Pollard, Laura E Nagy and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Carbamylated lipoproteins in diabetes.World journal of diabetes · 2023
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Stela Z BerishaDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Greg BrubakerDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Takhar KasumovDepartment of Gastroenterology and Hepatology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Kimberly T HungDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Patricia M DiBelloDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Ying HuangDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Ling LiDepartment of Research Core Services, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Belinda WillardDepartment of Research Core Services, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Katherine A PollardDepartment of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Laura E NagyDepartment of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Stanley L HazenDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44195.
Jonathan D SmithDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44195. Electronic address: smithj4@ccf.org.
Cleveland Clinic Lerner College of Medicine · USCleveland Clinic · USCase Western Reserve University · US

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Regression of Atherosclerosis CoreP01HL098055 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI DIDONATO, JOSEPH · 2010 to 2014
$12.1M
Pilot ProjectP20AA017837 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI FELDSTEIN, ARIEL · 2009 to 2013
$2.2M
Enabling studies of proteome dynamicsR21RR025346 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI KASUMOV, TAKHAR · 2009 to 2011
$583k
NCATS NIH HHS UL1 TR000439NCRR NIH HHS 5R21RR025346-03NCRR NIH HHS R21 RR025346NHLBI NIH HHS P01 HL098055NIAAA NIH HHS P20 AA017837
6 · The paper itself

Abstract

HDL functions are impaired by myeloperoxidase (MPO), which selectively targets and oxidizes human apoA1. We previously found that the 4WF isoform of human apoA1, in which the four tryptophan residues are substituted with phenylalanine, is resistant to MPO-mediated loss of function. The purpose of this study was to generate 4WF apoA1 transgenic mice and compare functional properties of the 4WF and wild-type human apoA1 isoforms in vivo. Male mice had significantly higher plasma apoA1 levels than females for both isoforms of human apoA1, attributed to different production rates. With matched plasma apoA1 levels, 4WF transgenics had a trend for slightly less HDL-cholesterol versus human apoA1 transgenics. While 4WF transgenics had 31% less reverse cholesterol transport (RCT) to the plasma compartment, equivalent RCT to the liver and feces was observed. Plasma from both strains had similar ability to accept cholesterol and facilitate ex vivo cholesterol efflux from macrophages. Furthermore, we observed that 4WF transgenic HDL was partially (∼50%) protected from MPO-mediated loss of function while human apoA1 transgenic HDL lost all ABCA1-dependent cholesterol acceptor activity. In conclusion, the structure and function of HDL from 4WF transgenic mice was not different than HDL derived from human apoA1 transgenic mice.

Indexed as

AnimalsApolipoprotein A-IATP Binding Cassette Transporter 1Cholesterol, HDLFemaleHumansMacrophagesMaleMiceMice, TransgenicOxidation-ReductionPeroxidaseProtein IsoformsStructure-Activity RelationshipABCA1 protein, humanAbca1 protein, mouseAPOA1 protein, humanApolipoprotein A-IATP Binding Cassette Transporter 1Cholesterol, HDLPeroxidaseProtein Isoformsapolipoprotein A1ATP binding cassette transporter A1cholesterol effluxdysfunctional high density lipoproteinmyeloperoxidasereverse cholesterol transport

Identifiers

PMID25561462
PMCPMC4340312
OpenAlexW2318361682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.